Search

1 to 10 of 415
Sort by

Library Entry
Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article showing that high numbers of both conventional and Tbet co-expressing Foxp3 hi Tregs accumulate in human papilloma virus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC). The infiltration of Tbet+...

SITC Education's profile image

Library Entry
Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article concludes that Hyperspectral Cell Sociology expands our understanding of the complex interplay between tumor cells and immune infiltrate. This technology could improve predictions of responses to immunotherapy and...


Library Entry
Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article indicating that the responsiveness of partially PDL1 + tumors correlates linearly with the percentage of PDL1 capable cells present at the initiation of treatment. Additionally, tumors which relapse after...


Library Entry
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-se

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on patients treated with immune-checkpoint blockade followed by targeted therapy, or vice versa, who experienced cutaneous toxicities with unique histological patterns, a feature that has not been well described in...


Library Entry
Advances in Cancer Immunotherapy™ Webinar Series: Updates from the Field - Clinical Updates from SITC 2018

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Christian M. Capitini, MD, and Zachary S. Morris,...


Library Entry
Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: ESMO Congress Clinical Trials Recording

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Theodore F. Logan, MD, and David F. McDermott, MD,...




Library Entry
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a man with Crohn’s disease actively requiring immunosuppressive therapy who subsequently received pembrolizumab for metastatic melanoma. Authors: Christopher C. Frohne , Ernesto M. Llano , Ashley Perkovic , ...


Library Entry
Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a 68-year-old with metastatic melanoma, who developed transverse myelitis in the setting of immune checkpoint blockade and spinal irradiation for vertebral metastases. Authors: Victoria A. Chang , Daniel R....